These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 36233432)

  • 1. Is Tocilizumab Plus Dexamethasone Associated with Superinfection in Critically Ill COVID-19 Patients?
    Camou F; Issa N; Hessamfar M; Guisset O; Mourissoux G; Pedeboscq S; Minot A; Bonnet F
    J Clin Med; 2022 Sep; 11(19):. PubMed ID: 36233432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and clinical outcomes of bacterial superinfections in critically ill patients with COVID-19.
    Yoon SM; Lee J; Lee SM; Lee HY
    Front Med (Lausanne); 2023; 10():1079721. PubMed ID: 36936237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early dexamethasone use as a protective measure in non-mechanically ventilated critically ill patients with COVID-19: a multicenter, cohort study.
    Al Sulaiman K; Korayem GB; Eljaaly K; Altebainawi AF; Al Harbi O; Badreldin HA; Al Harthi A; Al Yousif G; Vishwakarma R; Albelwi S; Almutairi R; Almousa M; Alghamdi R; Alhubaishi A; Alissa A; Alharbi A; Algarni R; Al Homaid S; Al Qahtani K; Akhani N; Al Atassi A; Al Ghamdi G; Aljuhani O
    Sci Rep; 2022 Jun; 12(1):9766. PubMed ID: 35697822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tocilizumab Outcomes in Critically Ill COVID-19 Patients Admitted to the ICU and the Role of Non-Tocilizumab COVID-19-Specific Medical Therapeutics.
    Elhazmi A; Rabie AA; Al-Omari A; Mufti HN; Sallam H; Alshahrani MS; Mady A; Alghamdi A; Altalaq A; Azzam MH; Sindi A; Kharaba A; Al-Aseri ZA; Almekhlafi GA; Tashkandi W; Alajmi SA; Faqihi F; Alharthy A; Al-Tawfiq JA; Melibari RG; Arabi YM
    J Clin Med; 2023 Mar; 12(6):. PubMed ID: 36983304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tocilizumab Is Associated with Increased Risk of Fungal Infections among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study.
    Burger BJ; Epps SM; Cardenas VM; Jagana R; Meena NK; Atchley WT
    Life (Basel); 2023 Aug; 13(8):. PubMed ID: 37629609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prompt Reduction in CRP, IL-6, IFN-γ, IP-10, and MCP-1 and a Relatively Low Basal Ratio of Ferritin/CRP Is Possibly Associated With the Efficacy of Tocilizumab Monotherapy in Severely to Critically Ill Patients With COVID-19.
    Hashimoto S; Yoshizaki K; Uno K; Kitajima H; Arai T; Tamura Y; Morishita H; Matsuoka H; Han Y; Minamoto S; Hirashima T; Yamada T; Kashiwa Y; Kameda M; Yamaguchi S; Tsuchihashi Y; Iwahashi M; Nakayama E; Shioda T; Nagai T; Tanaka T
    Front Med (Lausanne); 2021; 8():734838. PubMed ID: 34631752
    [No Abstract]   [Full Text] [Related]  

  • 7. Impact of immunosuppressive regimen on ICU acquired pneumonia in critically ill COVID-19.
    Villa A; Bougouin W; Urbina T; Bonny V; Gabarre P; Missri L; Baudel JL; Buzzi JC; Guidet B; Ait-Oufella H; Maury E; Joffre J
    Minerva Anestesiol; 2023 Sep; 89(9):783-791. PubMed ID: 37166347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corticosteroids and superinfections in COVID-19 patients on invasive mechanical ventilation.
    Søvik S; Barrat-Due A; Kåsine T; Olasveengen T; Strand MW; Tveita AA; Berdal JE; Lehre MA; Lorentsen T; Heggelund L; Stenstad T; Ringstad J; Müller F; Aukrust P; Holter JC; Nordøy I
    J Infect; 2022 Jul; 85(1):57-63. PubMed ID: 35605805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The modified NUTRIC score can be used for nutritional risk assessment as well as prognosis prediction in critically ill COVID-19 patients.
    Zhang P; He Z; Yu G; Peng D; Feng Y; Ling J; Wang Y; Li S; Bian Y
    Clin Nutr; 2021 Feb; 40(2):534-541. PubMed ID: 32527576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of cytokine blocking agents on hospital mortality in patients admitted to ICU with acute respiratory distress syndrome by SARS-CoV-2 infection: retrospective cohort study.
    Coloretti I; Busani S; Biagioni E; Venturelli S; Munari E; Sita M; DallAra L; Tosi M; Clini E; Tonelli R; Fantini R; Mussini C; Meschiari M; Guaraldi G; Cossarizza A; Alfano G; Girardis M
    Multidiscip Respir Med; 2021 Jan; 16(1):737. PubMed ID: 34040779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and risk factors for delirium in critically ill patients with COVID-19 (COVID-D): a multicentre cohort study.
    Pun BT; Badenes R; Heras La Calle G; Orun OM; Chen W; Raman R; Simpson BK; Wilson-Linville S; Hinojal Olmedillo B; Vallejo de la Cueva A; van der Jagt M; Navarro Casado R; Leal Sanz P; Orhun G; Ferrer Gómez C; Núñez Vázquez K; Piñeiro Otero P; Taccone FS; Gallego Curto E; Caricato A; Woien H; Lacave G; O'Neal HR; Peterson SJ; Brummel NE; Girard TD; Ely EW; Pandharipande PP;
    Lancet Respir Med; 2021 Mar; 9(3):239-250. PubMed ID: 33428871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical characteristics of critically ill pregnant women with different admission methods to intensive care unit: data analysis from 2006 to 2019 in the university hospital].
    Xi J; Ren H; Zhang H; Zhao Z; Wang T; Wang Z; Li W; Bo S; Yao G; Zhao Y; Wang Y; Ge Q
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Oct; 33(10):1249-1254. PubMed ID: 34955137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacterial pulmonary superinfections are associated with longer duration of ventilation in critically ill COVID-19 patients.
    Buehler PK; Zinkernagel AS; Hofmaenner DA; Wendel Garcia PD; Acevedo CT; Gómez-Mejia A; Mairpady Shambat S; Andreoni F; Maibach MA; Bartussek J; Hilty MP; Frey PM; Schuepbach RA; Brugger SD
    Cell Rep Med; 2021 Apr; 2(4):100229. PubMed ID: 33748789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study.
    COVID-ICU Group on behalf of the REVA Network and the COVID-ICU Investigators
    Intensive Care Med; 2021 Jan; 47(1):60-73. PubMed ID: 33211135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary Infections in Patients with COVID-19 Pneumonia Treated with Tocilizumab Compared to Those Not Treated with Tocilizumab: A Retrospective Study at a Tertiary Hospital in Kenya.
    Shah R; Shah J; Gohil J; Revathi G; Surani S
    Int J Gen Med; 2022; 15():2415-2425. PubMed ID: 35264878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanical ventilation parameters in critically ill COVID-19 patients: a scoping review.
    Grasselli G; Cattaneo E; Florio G; Ippolito M; Zanella A; Cortegiani A; Huang J; Pesenti A; Einav S
    Crit Care; 2021 Mar; 25(1):115. PubMed ID: 33743812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tocilizumab in the treatment of rapidly evolving COVID-19 pneumonia and multifaceted critical illness: A retrospective case series.
    Mady A; Aletreby W; Abdulrahman B; Lhmdi M; Noor AM; Alqahtani SA; Soliman I; Alharthy A; Karakitsos D; Memish ZA
    Ann Med Surg (Lond); 2020 Dec; 60():417-424. PubMed ID: 33169088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacterial and Fungal Superinfections in COVID-19 Patients Hospitalized in an Intensive Care Unit from Timișoara, Romania.
    Novacescu AN; Buzzi B; Bedreag O; Papurica M; Rogobete AF; Sandesc D; Sorescu T; Baditoiu L; Musuroi C; Vlad D; Licker M
    Infect Drug Resist; 2022; 15():7001-7014. PubMed ID: 36478964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term cognitive performance and its relation to anti-inflammatory therapy in a cohort of survivors of severe COVID-19.
    Duindam HB; Kessels RPC; van den Borst B; Pickkers P; Abdo WF
    Brain Behav Immun Health; 2022 Nov; 25():100513. PubMed ID: 36159208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of dexamethasone in patients with ARDS and COVID-19 - prospective, multi-centre, open-label, parallel-group, randomised controlled trial (REMED trial): A structured summary of a study protocol for a randomised controlled trial.
    Maláska J; Stašek J; Duška F; Balík M; Máca J; Hruda J; Vymazal T; Klementová O; Zatloukal J; Gabrhelík T; Novotný P; Demlová R; Kubátová J; Vinklerová J; Svobodník A; Kratochvíl M; Klučka J; Gál R; Singer M;
    Trials; 2021 Mar; 22(1):172. PubMed ID: 33648568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.